FIBRINOGEN SPLIT PRODUCTS, ANTIPROTEASES AND GRANULOCYTIC ELASTASE IN PATIENTS WITH LUNG-CANCER

被引:25
作者
GROPP, C
EGBRING, R
HAVEMANN, K
机构
关键词
D O I
10.1016/0014-2964(80)90209-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:679 / &
相关论文
共 13 条
[1]  
CARLSSON S, 1973, ACTA CHIR SCAND, V139, P499
[2]   COMPARATIVE STUDIES OF BLOOD COAGULATION AND PLATELET AGGREGATION IN PATIENTS WITH CANCER AND NONMALIGNANT DISEASES [J].
DAVIS, RB ;
THEOLOGIDES, A ;
KENNEDY, BJ .
ANNALS OF INTERNAL MEDICINE, 1969, 71 (01) :67-+
[3]   SIMPLE RADIOLOGICAL FACTOR-XIII DETERMINATION AND ITS CLINICAL APPLICATION (1) IN CONGENITAL FACTOR-XIII DEFICIENCY [J].
EGBRING, R ;
SCHMIDT, W ;
HAVEMANN, K .
BLUT, 1973, 27 (01) :6-19
[4]  
EGBRING R, 1977, BLOOD, V49, P219
[5]   DEGRADATION PRODUCTS OF FIBRINOGEN BY ELASTASE-LIKE NEUTRAL PROTEASE FROM HUMAN GRANULOCYTES - CHARACTERIZATION AND EFFECTS ON BLOOD-COAGULATION INVITRO [J].
GRAMSE, M ;
BINGENHEIMER, C ;
SCHMIDT, W ;
EGBRING, R ;
HAVEMANN, K .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (04) :1027-1033
[6]  
HAVEMANN K, 1974, 8TH P LEUC CULT C, P181
[7]  
HAVEMANN K, 1979, IMMUNDIAGNOSIS IMMUN, P56
[8]  
HEDNER U, 1971, ACTA MED SCAND, V189, P471
[10]  
O'MEARA R A, 1958, Ir J Med Sci, V394, P474